CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 366 filers reported holding CYTOKINETICS INC in Q4 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $172,000 | -85.8% | 3,180 | -81.6% | 0.00% | – |
Q1 2024 | $1,212,000 | -40.6% | 17,273 | -29.4% | 0.00% | – |
Q4 2023 | $2,042,000 | +3041.5% | 24,452 | +1001.9% | 0.00% | – |
Q3 2023 | $65,000 | -7.1% | 2,219 | +2.0% | 0.00% | – |
Q2 2023 | $70,000 | -70.5% | 2,176 | -67.7% | 0.00% | – |
Q1 2023 | $237,000 | -65.6% | 6,741 | -55.1% | 0.00% | – |
Q4 2022 | $688,000 | +391.4% | 15,026 | +418.0% | 0.00% | – |
Q3 2022 | $140,000 | -27.8% | 2,901 | -41.2% | 0.00% | – |
Q2 2022 | $194,000 | -22.4% | 4,937 | -27.5% | 0.00% | – |
Q1 2022 | $250,000 | -67.3% | 6,807 | -59.4% | 0.00% | – |
Q4 2021 | $764,000 | +108.2% | 16,772 | +63.2% | 0.00% | – |
Q3 2021 | $367,000 | +119.8% | 10,279 | +22.0% | 0.00% | – |
Q2 2021 | $167,000 | -60.3% | 8,422 | -53.4% | 0.00% | – |
Q1 2021 | $421,000 | -38.7% | 18,078 | -45.3% | 0.00% | – |
Q4 2020 | $687,000 | +53.0% | 33,031 | +59.2% | 0.00% | – |
Q3 2020 | $449,000 | +2.5% | 20,743 | +11.7% | 0.00% | – |
Q2 2020 | $438,000 | +90.4% | 18,567 | -4.9% | 0.00% | – |
Q1 2020 | $230,000 | +389.4% | 19,526 | +336.4% | 0.00% | – |
Q4 2019 | $47,000 | +291.7% | 4,474 | +326.1% | 0.00% | – |
Q3 2019 | $12,000 | -47.8% | 1,050 | -49.3% | 0.00% | – |
Q2 2019 | $23,000 | +35.3% | 2,073 | +0.3% | 0.00% | – |
Q1 2019 | $17,000 | +41.7% | 2,066 | +8.7% | 0.00% | – |
Q4 2018 | $12,000 | -62.5% | 1,900 | -40.6% | 0.00% | – |
Q3 2018 | $32,000 | +540.0% | 3,199 | +487.0% | 0.00% | – |
Q2 2018 | $5,000 | – | 545 | +1229.3% | 0.00% | – |
Q1 2018 | $0 | -100.0% | 41 | -94.6% | 0.00% | – |
Q4 2017 | $6,000 | -97.6% | 764 | -95.6% | 0.00% | – |
Q3 2017 | $250,000 | +57.2% | 17,181 | +31.1% | 0.00% | – |
Q2 2017 | $159,000 | -11.7% | 13,106 | -6.5% | 0.00% | – |
Q1 2017 | $180,000 | +566.7% | 14,015 | +555.8% | 0.00% | – |
Q4 2016 | $27,000 | +170.0% | 2,137 | +36.4% | 0.00% | – |
Q3 2015 | $10,000 | -23.1% | 1,567 | -19.3% | 0.00% | – |
Q2 2015 | $13,000 | -97.9% | 1,942 | -98.5% | 0.00% | – |
Q2 2014 | $621,000 | -62.7% | 130,000 | -25.9% | 0.00% | -100.0% |
Q1 2014 | $1,666,000 | +55433.3% | 175,390 | +48891.6% | 0.00% | – |
Q3 2013 | $3,000 | – | 358 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |